Your browser doesn't support javascript.
loading
Long-term visual acuity outcomes following cataract surgery in eyes with ocular inflammatory disease.
Gangaputra, Sapna; Newcomb, Craig; Armour, Rebecca; Choi, Dongseok; Ying, Gui-Shuang; Groth, Sylvia; Begum, Hosne; Fitzgerald, Tonetta; Artornsombudh, Pichaporn; Daniel, Ebenezer; Bhatt, Nirali; Foster, Stephen; Jabs, Douglas; Levy-Clarke, Grace; Nussenblatt, Robert; Rosenbaum, James T; Sen, H Nida; Suhler, Eric; Thorne, Jennifer; Dreger, Kurt; Buchanich, Jeanine; Kempen, John H.
Afiliação
  • Gangaputra S; Vanderbilt Eye Institute, Nashville, Tennessee, USA sapna.gangaputra@vumc.org.
  • Newcomb C; Department of Biostatistics and Epidemiology, Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA.
  • Armour R; Department of Ophthalmology, Oregon Health & Science University School of Medicine, Portland, Oregon, USA.
  • Choi D; Public Health and Preventive Medicine, Oregon Health & Science University School of Medicine, Portland, Oregon, USA.
  • Ying GS; Ophthalmology, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA.
  • Groth S; Vanderbilt Eye Institute, Nashville, Tennessee, USA.
  • Begum H; Wilmer Eye Institute, Johns Hopkins Medicine School of Medicine, Baltimore, Maryland, USA.
  • Fitzgerald T; Ophthalmology, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA.
  • Artornsombudh P; Ophthalmology, Somdech Phra Pinklao Hospital, Bangkok, Thailand.
  • Daniel E; Chulalongkorn University, Bangkok, Thailand.
  • Bhatt N; Ophthalmology, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA.
  • Foster S; Ophthalmology, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA.
  • Jabs D; Massachusetts Eye Research and Surgery Institution, Waltham, Massachusetts, USA.
  • Levy-Clarke G; Sight for Souls, Fort Myers, Florida, USA.
  • Nussenblatt R; Wilmer Eye Institute, Johns Hopkins Medicine School of Medicine, Baltimore, Maryland, USA.
  • Rosenbaum JT; Center for Clinical Trials and Evidence Synthesis, Johns Hopkins University Bloomberg School of Public Health, Baltimore, Maryland, USA.
  • Sen HN; Laboratory of Immunology, National Eye Institute, Bethesda, Maryland, USA.
  • Suhler E; The Tampa Bay Uveitis Center, St Petersburg, Florida, USA.
  • Thorne J; Laboratory of Immunology, National Eye Institute, Bethesda, Maryland, USA.
  • Dreger K; Department of Ophthalmology, Oregon Health & Science University School of Medicine, Portland, Oregon, USA.
  • Buchanich J; Casey Eye Institute, Oregon Health & Science University, Portland, Oregon, USA.
  • Kempen JH; Legacy Devers Eye Institute at Good Samaritan Medical Center, Portland, Oregon, USA.
Br J Ophthalmol ; 108(3): 380-385, 2024 02 21.
Article em En | MEDLINE | ID: mdl-36810151
ABSTRACT

PURPOSE:

To evaluate the long-term visual acuity (VA) outcome of cataract surgery in inflammatory eye disease.

SETTING:

Tertiary care academic centres.

DESIGN:

Multicentre retrospective cohort study.

METHODS:

A total of 1741 patients with non-infectious inflammatory eye disease (2382 eyes) who underwent cataract surgery while under tertiary uveitis management were included. Standardised chart review was used to gather clinical data. Multivariable logistic regression models with adjustment for intereye correlations were performed to evaluate the prognostic factors for VA outcomes. Main outcome measure was VA after cataract surgery.

RESULTS:

Uveitic eyes independent of anatomical location showed improved VA from baseline (mean 20/200) to within 3 months (mean 20/63) of cataract surgery and maintained through at least 5 years of follow-up (mean 20/63). Eyes that achieved 20/40 or better VA at 1 year were more likely to have scleritis (OR=1.34, p<0.0001) or anterior uveitis (OR=2.2, p<0.0001), VA 20/50 to 20/80 (OR 4.76 as compared with worse than 20/200, p<0.0001) preoperatively, inactive uveitis (OR=1.49, p=0.03), have undergone phacoemulsification (OR=1.45 as compared with extracapsular cataract extraction, p=0.04) or have had intraocular lens placement (OR=2.13, p=0.01). Adults had better VA immediately after surgery, with only 39% (57/146) paediatric eyes at 20/40 or better at 1 year.

CONCLUSIONS:

Our results suggest that adult and paediatric eyes with uveitis typically have improved VA following cataract surgery and remain stable thereafter for at least 5 years.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Uveíte / Catarata / Extração de Catarata / Doenças da Túnica Conjuntiva / Facoemulsificação Tipo de estudo: Observational_studies / Prognostic_studies Limite: Adult / Child / Humans Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Uveíte / Catarata / Extração de Catarata / Doenças da Túnica Conjuntiva / Facoemulsificação Tipo de estudo: Observational_studies / Prognostic_studies Limite: Adult / Child / Humans Idioma: En Ano de publicação: 2024 Tipo de documento: Article